BioNTech SEEquity-NMS: BNTX
Equity-NMS: BNTX
$90.61
-2.37
(17 May)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$90.61
Open
$90.61
Today’s high
$92.80
Today’s low
$90.53
52W low
$85.21
52W high
$125.83
1Y
-13.66%
PE
157.19
EPS (TTM)
0.58
Shares O/S
237.73M
Market cap
21.54B
Insights
BNTX PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About BioNTech SE

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner.

It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders. .


FAQs

Can I buy BioNTech SE shares in India?
How to buy BioNTech SE shares in India?
What is the share price of BioNTech SE?
What is the Market Capitalization of BioNTech SE?
What is the PE ratio of BioNTech SE?
Is BioNTech SE a good stock to buy?
In which sector / industry does BioNTech SE operate?